The glucuronolactone market is anticipated to grow significantly from USD 298.8 million in 2025 to USD 645.2 million by 2035, registering a strong CAGR of 8.0% over the forecast period.
North America stands out as the most lucrative regional market, driven by the high consumption of energy drinks and sports supplements. Meanwhile, East Asia is projected to exhibit the fastest growth owing to an uptick in fitness culture, the expansion of the functional food sector, and increased awareness about performance-enhancing ingredients.
The market is being shaped by rising demand for ingredients that support liver detoxification, reduce fatigue, and improve physical and mental performance. Glucuronolactone is increasingly favored in the formulation of energy drinks and dietary supplements due to its role in enhancing alertness and stamina.
Key trends include the proliferation of clean-label performance drinks and a preference for synergistic blends with caffeine and taurine. Despite this momentum, limited consumer education in emerging markets and inconsistent global regulatory frameworks may pose hurdles to broader adoption. Industry players are actively addressing these gaps by reinforcing R&D pipelines, ensuring purity compliance, and optimizing sourcing strategies to meet evolving customer expectations.
| Metrics | Values |
|---|---|
| Industry Size (2025E) | USD 298.8 million |
| Industry Value (2035F) | USD 645.2 million |
| CAGR (2025 to 2035) | 8.0% |
Looking forward, the market is expected to expand into new functional categories, including cognitive support and detoxification supplements, especially as scientific validation and clinical evidence continue to build. Product differentiation through innovative formats-such as capsules, sachets, and RTD (ready-to-drink) blends-will likely be central to growth strategies.
Furthermore, sustainability in manufacturing, transparent labeling, and pharmaceutical-grade certification are anticipated to become pivotal differentiators. Market success will increasingly depend on the ability to cater to high-performance lifestyle consumers while aligning with regulatory and clean-label demands.
The table below presents a comparative assessment of the variation in CAGR over six months for the base year (2024) and the current year (2025) for the industry. This analysis highlights crucial shifts in industry performance and provides insights into revenue realization patterns, offering stakeholders a clear perspective on the industry’s growth trajectory.
| Particular | H1 |
|---|---|
| Year | 2024 to 2034 |
| Value CAGR | 7.0% |
| Particular | H2 |
|---|---|
| Year | 2024 to 2034 |
| Value CAGR | 7.6% |
| Particular | H1 |
|---|---|
| Year | 2025 to 2035 |
| Value CAGR | 7.2% |
| Particular | H2 |
|---|---|
| Year | 2025 to 2035 |
| Value CAGR | 7.8% |
The first half (H1) of the year spans from January to June, while the second half (H2) includes the months from July to December. From H1 2024 to H2 2034, the industry is expected to grow at a CAGR of 3.9%, followed by a higher growth rate of 4.1% in the second half (H2) of the same decade.
Moving forward, from H1 2025 to H2 2035, the industry is projected to expand at a CAGR of 4.5% in the first half and maintain an upward trend at 4.7% in the second half. In H1, the industry observed an increase of 20 BPS, while in H2, the industry experienced a further rise of 20 BPS.
The industry is growing because the product is found in widespread application in energy drinks, dietary supplements, pharmaceuticals, and functional foods. Production is given preference by manufacturers as high-quality manufacturing, regulatory approvals, and cheap synthesis are undertaken to cater to increasing demand. Distributors take actions to maintain supply chain efficiency in order to guarantee availability across industries.
Retailers provide health-conscious consumers with mixes of branded and store-brand products containing it using price matching versus premium product positioning. Final consumers, e.g., healthy-conscious consumers, athletes, and body builders, demand purity, efficacy, and value in choosing products.
Consumers' increased inclination toward performance enhancement and clean-label ingredients are pressurizing formulators with their drive towards the former and favorable consumer reception with the latter. Regulatory approvals, safety evaluations, and scientific studies supporting the advantages of it for cognitive functions and detoxification also fuel purchases across segments.
Accounting for 58.4% of global market share in 2025, the energy drinks segment anchors glucuronolactone demand and is projected to grow in line with the overall 8.0% CAGR through 2035. This commanding position reflects glucuronolactone’s entrenched role in performance-focused functional beverages, particularly those targeting mental acuity, physical endurance, and rapid recovery.
Energy drink brands have long favored glucuronolactone for its synergistic interaction with caffeine and taurine, enhancing perceived energy and alertness without increasing sugar loads. As consumer profiles shift toward health-conscious millennials and Gen Z athletes, demand is migrating from traditional carbonated formats to clean-label, plant-forward formulations, where glucuronolactone continues to offer a scientific edge. Regulatory acceptance in major markets like the USA, Europe, and Japan has further validated its inclusion in high-performance beverage portfolios.
Leading manufacturers are innovating around bioavailability and stability-integrating glucuronolactone into novel RTD blends, shots, and functional waters. The segment’s continued strength also hinges on its adaptability to broader positioning, including cognitive function, mood elevation, and liver health.
While competition from nootropics and adaptogens is intensifying, glucuronolactone’s established presence and expanding clinical evidence base support its strategic value in next-generation energy beverages. Forward-looking players are leveraging this molecule not merely as a stimulant adjunct, but as a core driver of performance differentiation.
The dietary supplements segment is projected to grow at a CAGR exceeding 8.5% through 2035, gradually capturing a larger share of the global glucuronolactone market. While energy drinks remain the dominant application, supplements are emerging as a high-potential growth vector, fueled by consumer interest in multifunctional health products that support detoxification, cognitive performance, and overall vitality.
Glucuronolactone’s bioactive profile aligns well with trends favoring natural liver support and fatigue mitigation, especially in urban populations exposed to stress, pollution, and lifestyle-induced toxin buildup. Supplement manufacturers are increasingly incorporating it into standalone capsules, liver health blends, and metabolic booster stacks-often positioned alongside ingredients such as milk thistle, B-vitamins, and alpha-lipoic acid. These combinations target preventive wellness users seeking daily detoxification and long-term organ support without pharmaceutical intervention.
Some significant threats that the industry contends with include strict regulation, raw material price fluctuations, changes in consumer preference, pressure from rivals, and unreliable supply chains.
Regulatory scrutiny is the most alarming factor, especially considering that it is an ingredient found in energy drinks, dietary supplements, and уф medications. There are voices from certain health authorities questioning its adverse health effects at high concentrations, and that could probably cause a ban on it. The European Food Safety Authority (EFSA) and the USA Food and Drug Administration (FDA) have issued their directives, however, amendments in regulations may have an effect on the inclusion of this substance in energy drinks and functional foods.
With the price volatility of raw materials, the production costs are also affected, since it is made from glucose that has been fermented or was synthesized chemically. Variations in sugar supply chains, an increase in manufacturing costs, or a rise in demand for glucose-based products may impact industry pricing and availability.
Changing consumer preferences have a direct influence on demand, particularly in the functional beverage and dietary supplement sectors. Even if the energy drink industry is still booming, rising worries about caffeine and stimulant overuse could have a detrimental effect on the glucuronolactone product consumption. The shift to natural ingredients and plant-based alternatives is also another way of dealing with it.
Competitive forces are both synthetics and naturals such as taurine, L-carnitine, or even herbal extracts which do almost the same work, increase energy and detoxify the body. They must set their glucuronolactone products apart from the rest to hold on to their industry share.
Decentralized gasps in supply chains including transport hurdles, raw materials, or war-related factors may guide the availability of it. On top of that, there is the issue of reliance on China, the USA, and Europe for production which in turn means that barriers to trade or global crises would bring on uncertainties.
| Countries | CAGR (2025 to 2035) |
|---|---|
| USA | 6.7% |
| China | 5.0% |
| Germany | 3.8% |
| India | 4.01% |
| Brazil | 5.2% |
The USA industry is witnessing steady growth, with an expected CAGR of 6.7% over 2025 to 2032, cites FMI. Rising demand for energy drinks and dietary supplements has driven the development, with customers demanding products that improve cognitive ability and combat fatigue. Functional drinks containing it are becoming increasingly popular among professionals, sportspeople, and fitness enthusiasts.
Major players continue to include this ingredient in their products to cater to an emerging health-conscious consumer base. Moreover, the pharmaceutical industry is looking into its use in detoxification and mental health, further expanding industry potential. FMI believes that the USA industry will expand at 6.7% CAGR over the forecast period.
Growth Drivers in the USA
| Key Drivers | Details |
|---|---|
| Growing demand for energy drinks | Consumers look for improvement in cognitive and physical performance. |
| Rising health awareness | Functional ingredients are mainstream in well-being trends. |
| Growing dietary supplement industry | It finds application in sports and mental supplements. |
| Well-established retailer shelf presence | Easy access by online and offline channels. |
The Chinese industry is anticipated to expand at a CAGR of 5.0% during the forecast period, cites FMI. A surging middle-class population, higher disposable incomes, and health-focused choices of consumers contribute to this expansion.
It is already found in most present-day energy beverages as a dominant ingredient in augmenting mental and physical performance. Additionally, government-sponsored well-being programs have supported functional foods and dietary supplements. China remains a leading producer, with a secure supply to accommodate domestic and export demand.
Growth Drivers in China
| Key Drivers | Details |
|---|---|
| The growing functional beverage industry | Glucuronolactone-fortified energy drinks have increased in popularity. |
| Expanding consumer group of middle-class | Growing disposable income supports the uptake of premium products. |
| Government-funded health programs | Health awareness promotions stimulate the use of functional ingredients. |
| Stable local production | China continues to be a major producer in global supply. |
The German industry is anticipated to expand at a CAGR of 3.8% during 2025 to 2032 as consumers highly sought natural and science-backed health products. Pharmaceutical and nutraceutical firms concentrate on research-backed, high-value formulations. It has been recognized as an ingredient with cognitive effects and for energy boosts in dietary supplements. With strict regulatory measures guaranteeing product safety, consumers trust it.
It is also used extensively in liver health supplements and detoxification in the pharmaceutical sector. FMI anticipates the German industry will register a 3.8% CAGR during the forecast period.
Growth Drivers in Germany
| Key Drivers | Details |
|---|---|
| Healthy focus on wellness and well-being | Clients favor science-established functional ingredients. |
| Expanding growth of nutraceuticals | Rising demand for dietary supplements containing it. |
| Stringent regulatory requirements | Safeguards high-value products and ensures consumer safety. |
| Pharmaceutical use expansion | Increasing use of it in detox and cognitive health products. |
India's industry is expected to grow consistently at a CAGR of 4.01% from 2025 to 2032. The increasing trend of functional beverages and energy supplements has driven industry growth. With increasingly active lifestyles, the demand for glucuronolactone-based products has been rising. Online and offline platforms have made these products more accessible. The pharmaceutical sector also investigates its applications in well-being and liver health products.
Growth Drivers in India
| Key Drivers | Details |
|---|---|
| Enhanced health awareness | Consumers opt for functional and performance-improving ingredients. |
| Growing energy drink industry | Improved distribution of glucuronolactone-based beverages. |
| Retail and e-commerce growth | Internet stores offer more convenient access to the supplement. |
| Rising pharmaceutical use | Research establishes the detoxification effect of it. |
The growing popularity of sports nutrition products and energy drinks due to an increasing fitness culture has played a pivotal role in industry expansion. It is currently a standard ingredient in functional drinks targeting endurance and cognitive performance.
International players are increasing their foothold in Brazil, bringing innovative formulations that align with evolving health trends. The nutraceutical industry is also rising, with increased supplement consumption across various consumer groups. According to FMI, the Brazilian industry is expected to grow at 5.2% CAGR throughout the forecast period.
Growth Drivers in Brazil
| Key Drivers | Details |
|---|---|
| Growing sports nutrition needs | A stronger fitness culture promotes supplement intake. |
| Functional drink development | Energy beverages containing it are increasingly popular. |
| Expansion by international brands | International firms introduce new formulations based on health trends. |
| Heightened use of supplements | Consumers seek mental and physical performance enhancers. |
Roquette Frères (18-22%)
A significant player, being well-known for high-purity formulations, servicing the energy drink and pharmaceutical industries.
Jungbunzlauer Suisse AG (12-16%)
The company specializes in sustainable production and high-quality for nutraceutical applications.
Foodchem International Corporation (10-14%)
One of the important suppliers of it for food, beverage, and pharmaceutical manufacturers all around the world.
Shandong Fuyang Bio-Tech Co., Ltd. (9-13%)
Enhanced production capacity with an eye on increasing demand for functional beverages and supplements.
Anhui Fubare Pharmaceutical & Chemical Co. (8-12%)
Manufacturer of pharmaceutical-grade, which benefits from R&D for product newness.
Other Key Players (25-35% Combined)
By form, the industry is segmented into powder, liquid, and tablet & capsules.
By end use, the industry is segmented into dietary supplements, energy drinks, pharmaceuticals, cosmetics, and functional foods.
By region, the industry is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA).
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Volume (MT) Forecast by Region, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 4: Global Market Volume (MT) Forecast by Form, 2018 to 2033
Table 5: Global Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 6: Global Market Volume (MT) Forecast by End Use, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: North America Market Volume (MT) Forecast by Country, 2018 to 2033
Table 9: North America Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 10: North America Market Volume (MT) Forecast by Form, 2018 to 2033
Table 11: North America Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 12: North America Market Volume (MT) Forecast by End Use, 2018 to 2033
Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Latin America Market Volume (MT) Forecast by Country, 2018 to 2033
Table 15: Latin America Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 16: Latin America Market Volume (MT) Forecast by Form, 2018 to 2033
Table 17: Latin America Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 18: Latin America Market Volume (MT) Forecast by End Use, 2018 to 2033
Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: Western Europe Market Volume (MT) Forecast by Country, 2018 to 2033
Table 21: Western Europe Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 22: Western Europe Market Volume (MT) Forecast by Form, 2018 to 2033
Table 23: Western Europe Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 24: Western Europe Market Volume (MT) Forecast by End Use, 2018 to 2033
Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: Eastern Europe Market Volume (MT) Forecast by Country, 2018 to 2033
Table 27: Eastern Europe Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 28: Eastern Europe Market Volume (MT) Forecast by Form, 2018 to 2033
Table 29: Eastern Europe Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 30: Eastern Europe Market Volume (MT) Forecast by End Use, 2018 to 2033
Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 32: South Asia and Pacific Market Volume (MT) Forecast by Country, 2018 to 2033
Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 34: South Asia and Pacific Market Volume (MT) Forecast by Form, 2018 to 2033
Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 36: South Asia and Pacific Market Volume (MT) Forecast by End Use, 2018 to 2033
Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 38: East Asia Market Volume (MT) Forecast by Country, 2018 to 2033
Table 39: East Asia Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 40: East Asia Market Volume (MT) Forecast by Form, 2018 to 2033
Table 41: East Asia Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 42: East Asia Market Volume (MT) Forecast by End Use, 2018 to 2033
Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 44: Middle East and Africa Market Volume (MT) Forecast by Country, 2018 to 2033
Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Form, 2018 to 2033
Table 46: Middle East and Africa Market Volume (MT) Forecast by Form, 2018 to 2033
Table 47: Middle East and Africa Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Table 48: Middle East and Africa Market Volume (MT) Forecast by End Use, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Form, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by End Use, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Volume (MT) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 9: Global Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 10: Global Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 11: Global Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 12: Global Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 13: Global Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 14: Global Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 15: Global Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 16: Global Market Attractiveness by Form, 2023 to 2033
Figure 17: Global Market Attractiveness by End Use, 2023 to 2033
Figure 18: Global Market Attractiveness by Region, 2023 to 2033
Figure 19: North America Market Value (US$ Million) by Form, 2023 to 2033
Figure 20: North America Market Value (US$ Million) by End Use, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 23: North America Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 26: North America Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 27: North America Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 28: North America Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 29: North America Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 30: North America Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 31: North America Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 34: North America Market Attractiveness by Form, 2023 to 2033
Figure 35: North America Market Attractiveness by End Use, 2023 to 2033
Figure 36: North America Market Attractiveness by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) by Form, 2023 to 2033
Figure 38: Latin America Market Value (US$ Million) by End Use, 2023 to 2033
Figure 39: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 41: Latin America Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 45: Latin America Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 49: Latin America Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 50: Latin America Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 52: Latin America Market Attractiveness by Form, 2023 to 2033
Figure 53: Latin America Market Attractiveness by End Use, 2023 to 2033
Figure 54: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 55: Western Europe Market Value (US$ Million) by Form, 2023 to 2033
Figure 56: Western Europe Market Value (US$ Million) by End Use, 2023 to 2033
Figure 57: Western Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 58: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 59: Western Europe Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 62: Western Europe Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 63: Western Europe Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 66: Western Europe Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 67: Western Europe Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 68: Western Europe Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 70: Western Europe Market Attractiveness by Form, 2023 to 2033
Figure 71: Western Europe Market Attractiveness by End Use, 2023 to 2033
Figure 72: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 73: Eastern Europe Market Value (US$ Million) by Form, 2023 to 2033
Figure 74: Eastern Europe Market Value (US$ Million) by End Use, 2023 to 2033
Figure 75: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 76: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 77: Eastern Europe Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 80: Eastern Europe Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 81: Eastern Europe Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 84: Eastern Europe Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 85: Eastern Europe Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 88: Eastern Europe Market Attractiveness by Form, 2023 to 2033
Figure 89: Eastern Europe Market Attractiveness by End Use, 2023 to 2033
Figure 90: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 91: South Asia and Pacific Market Value (US$ Million) by Form, 2023 to 2033
Figure 92: South Asia and Pacific Market Value (US$ Million) by End Use, 2023 to 2033
Figure 93: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: South Asia and Pacific Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 98: South Asia and Pacific Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 99: South Asia and Pacific Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 102: South Asia and Pacific Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 103: South Asia and Pacific Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 106: South Asia and Pacific Market Attractiveness by Form, 2023 to 2033
Figure 107: South Asia and Pacific Market Attractiveness by End Use, 2023 to 2033
Figure 108: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033
Figure 109: East Asia Market Value (US$ Million) by Form, 2023 to 2033
Figure 110: East Asia Market Value (US$ Million) by End Use, 2023 to 2033
Figure 111: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 112: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 113: East Asia Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 116: East Asia Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 117: East Asia Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 118: East Asia Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 120: East Asia Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 121: East Asia Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 122: East Asia Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 123: East Asia Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 124: East Asia Market Attractiveness by Form, 2023 to 2033
Figure 125: East Asia Market Attractiveness by End Use, 2023 to 2033
Figure 126: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 127: Middle East and Africa Market Value (US$ Million) by Form, 2023 to 2033
Figure 128: Middle East and Africa Market Value (US$ Million) by End Use, 2023 to 2033
Figure 129: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 130: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 131: Middle East and Africa Market Volume (MT) Analysis by Country, 2018 to 2033
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Form, 2018 to 2033
Figure 135: Middle East and Africa Market Volume (MT) Analysis by Form, 2018 to 2033
Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Form, 2023 to 2033
Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Form, 2023 to 2033
Figure 138: Middle East and Africa Market Value (US$ Million) Analysis by End Use, 2018 to 2033
Figure 139: Middle East and Africa Market Volume (MT) Analysis by End Use, 2018 to 2033
Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033
Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033
Figure 142: Middle East and Africa Market Attractiveness by Form, 2023 to 2033
Figure 143: Middle East and Africa Market Attractiveness by End Use, 2023 to 2033
Figure 144: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
The industry is expected to reach USD 298.8 million in 2025.
The industry is projected to reach USD 645.2 million by 2035.
The key players in the industry include Aceto Corporation, Anhui Fubore Pharmaceutical & Chemical Co., Ltd., Merck Millipore Corporation, Hubei Yitai Pharmaceutical Co., Ltd., Shaoxing Marina Biotechnology Co., Ltd., Foodchem International Corporation, Shandong Fuyang Bio-Tech Co., Ltd., Roquette Frères, Jungbunzlauer Suisse AG, and Suzhou Fifth Pharmaceutical Factory Co.
The USA, slated to grow at a CAGR of 6.7% during the forecast period, is expected to see fastest growth.
Powdered form is being widely used.
Glucuronolactone Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
